clinical trials

Novartis gears up for label expansion for Kisqali with Phase III results
Clinical Trials Arena
Mon, 12/11/23 - 11:18 am
Novartis
Kisqali
FDA
clinical trials
early breast cancer
breast cancer
ASH: With high tumor response, AstraZeneca spinout Dizal explores FDA path and US partner for PTCL drug
Fierce Biotech
Mon, 12/11/23 - 10:09 am
AstraZeneca
Dizal Pharmaceutical
blood cancer
peripheral T cell lymphoma
golidocitinib
clinical trials
Moderna, Merck begin late-stage study for mRNA cancer therapy
Reuters
Mon, 12/11/23 - 10:00 am
Moderna Therapeutics
Merck
MRNA
cancer
clinical trials
AbbVie and Genmab report data from follicular lymphoma antibody trial
Clinical Trials Arena
Mon, 12/11/23 - 09:59 am
AbbVie
Genman
clinical trials
epcoritamab
bispecific antibodies
relapsed or refractory follicular lymphoma
Roche’s Hemlibra shows benefit in Phase III hemophilia A trial
Clinical Trials Arena
Mon, 12/11/23 - 09:57 am
Roche
Hemlibra
hemophilia A
clinical trials
Merck suffers bad week as 3 Keytruda combination trials fail
BioPharma Dive
Sun, 12/10/23 - 11:19 pm
Merck
Keytruda
clinical trials
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer
BioSpace
Fri, 12/8/23 - 10:00 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
metastatic colorectal cancer
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
Regeneron touts possible 'best-in-class' myeloma bispecific, but adverse events climb to 100%
Fierce Biotech
Thu, 12/7/23 - 11:52 am
Regeneron
clinical trials
bispecific
Multiple Myeloma
patient deaths
linvoseltamab
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Clinical Trials Arena
Thu, 12/7/23 - 11:02 am
Seagen
Tukysa
clinical trials
HER2-positive breast cancer
Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial
Clinical Trials Arena
Thu, 12/7/23 - 10:13 am
Insilico
ulcerative colitis
clinical trials
NCT06012578
Merck KGaA’s BTK Inhibitor Fails Phase III Multiple Sclerosis Studies
BioSpace
Wed, 12/6/23 - 10:44 am
Merck KGaA
evobrutinib
clinical trials
relapsing multiple sclerosis
MS
Pharvaris' oral hereditary angioedema med slashes attacks in turnaround post-FDA hold
Fierce Biotech
Wed, 12/6/23 - 10:34 am
Pharvaris
HAE
clinical trials
deucrictibant
NeuroSense’s trial of ALS drug meets primary and secondary endpoints
Clinical Trials Arena
Wed, 12/6/23 - 10:22 am
NeuroSense Therapeutics
clinical trials
PrimeC
ALS
Roche reports positive Phase III data for breast cancer therapy
Clinical Trials Arena
Tue, 12/5/23 - 09:56 am
Roche
clinical trials
inavolisib
metastatic breast cancer
breast cancer
Alto’s Neuropsychiatric Platform Scores Third Mid-Stage Win
BioSpace
Tue, 12/5/23 - 09:55 am
Alto Neuroscience
ALTO-300
major depressive disorder
clinical trials
‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs
Fierce Biotech
Tue, 12/5/23 - 09:46 am
BrainChild Bio
pediatric cancer
clinical trials
CAR-T
oncology
brain cancer
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Genentech
Roche
MS
multiple sclerosis
fenebrutinib
clinical trials
EyePoint Pharma Stock Surges on Phase II Wet AMD-Therapy Results
BioSpace
Mon, 12/4/23 - 06:12 pm
Eyepoint
clinical trials
wet age-related macular degeneration
Eylea
EYP-1901

Pages